| Dr Manuel Dumlao, MD | |
|
2314 Monroe St, Dearborn, MI 48124-3045 | |
| (313) 562-6633 | |
| (313) 562-0880 |
| Full Name | Dr Manuel Dumlao |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 2314 Monroe St, Dearborn, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184683856 | NPI | - | NPPES |
| 2608218572 | Other | MI | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 4301047459 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Manuel Dumlao, MD 17655 Cooley St, Detroit, MI 48219-2371 Ph: (313) 538-5244 | Dr Manuel Dumlao, MD 2314 Monroe St, Dearborn, MI 48124-3045 Ph: (313) 562-6633 |
News Archive
Novartis announced new analyses of data for once-daily Ultibro® Breezhaler® (investigational QVA149 - indacaterol 85 mcg/glycopyrronium 43 mcg delivered dose, equivalent to 110 mcg/50 mcg metered dose per capsule), which showed significant improvements in lung function, shortness of breath and health-related quality of life for chronic obstructive pulmonary disease (COPD) patients versus all comparators1,2. These data were part of 39 respiratory abstracts presented at the European Respiratory Society (ERS) Annual Congress in Barcelona, Spain.
Longtime environmental health researchers at Tufts University School of Medicine describe the carcinogenic effects of endocrine-disrupting chemicals, ubiquitous chemicals that have hormone-like effects in the body. In a review article published online May 25 in Nature Reviews Endocrinology, the researchers express the need for more complex strategies for studying how these chemicals affect health but report that ample evidence already supports changing public health and environmental policies to protect the public from exposure to EDCs.
A drug recently approved for use in multiple myeloma is now being tested for its ability to fight central nervous system (CNS) lymphoma, a deadly cancer of the immune system that can affect the brain, spinal cord and fluid, and eyes.
In this pair of articles, Modern Healthcare reports on the American Hospital Association's criticism of the antitrust approach included in the accountable care organization regulations recently released by the Department of Health and Human Services, as well as on the negative reaction expressed by a Cleveland Clinic executive.
Contrary to earlier reports, a new study finds that stress does not appear to increase a person's risk of developing multiple sclerosis. The research is published in the May 31, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
Nathan Lwo, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 | |
Parthkumar Patel, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 | |
Dora Mell, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 | |
Ethan Aleksandr Bork, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 | |
Dr. Suheb Mashkoor Hasan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3815 Pelham St, Ste 1, Dearborn, MI 48124 Phone: 313-593-3915 Fax: 313-792-8812 | |
Dr. Hassan Mohamed Barade, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 |